Norge -
norsk -
Statens legemiddelverk
zantac 150 mg
glaxosmithkline as - ranitidinhydroklorid - brusetablett - 150 mg
Norge -
norsk -
Statens legemiddelverk
zantac 25 mg/ ml
glaxosmithkline as - ranitidinhydroklorid - injeksjonsvæske, oppløsning - 25 mg/ ml
Norge -
norsk -
Statens legemiddelverk
zantac 150 mg
glaxosmithkline as - ranitidinhydroklorid - tablett - 150 mg
Norge -
norsk -
Statens legemiddelverk
zantac 75 mg
farmagon - ranitidinhydroklorid - tablett - 75 mg
Den europeiske union -
norsk -
EMA (European Medicines Agency)
symkevi
vertex pharmaceuticals (ireland) limited - tezacaftor, ivacaftor - cystisk fibrose - andre åndedrettsprodukter - symkevi is indicated in a combination regimen with ivacaftor tablets for the treatment of patients with cystic fibrosis (cf) aged 6 years and older who are homozygous for the f508del mutation or who are heterozygous for the f508del mutation and have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (cftr) gene: p67l, r117c, l206w, r352q, a455e, d579g, 711+3a→g, s945l, s977f, r1070w, d1152h, 2789+5g→a, 3272 26a→g, and 3849+10kbc→t.
Norge -
norsk -
Statens legemiddelverk
carbidopa/levodopa fair-med 12.5 mg / 50 mg
fair-med healthcare gmbh - karbidopamonohydrat / levodopa - tablett - 12.5 mg / 50 mg
Norge -
norsk -
Statens legemiddelverk
carbidopa/levodopa fair-med 25 mg / 100 mg
fair-med healthcare gmbh - karbidopamonohydrat / levodopa - tablett - 25 mg / 100 mg
Norge -
norsk -
Statens legemiddelverk
questran loc 4 g
orifarm as - kolestyramin - pulver til mikstur, suspensjon - 4 g